Anthropic Says Claude Found Something Big in DNA. It Just Doesn't Know What

Anthropic said its AI model Claude examined large DNA sequence datasets and identified an unusual molecular system it is calling ART, short for array-associated reverse transcriptases. The putative system appeared in bacteriophage genomes adjacent to repeating DNA segments that resemble CRISPR arrays. Anthropic reported that Claude winnowed a pool of over 200,000 reverse transcriptase–like sequences down to roughly 3,500 atypical candidates and then selected about 20 for deeper analysis. The company emphasized that the discovery is an early-stage computational result. CEO Dario Amodei acknowledged that the precise biological function of ART, any potential biotechnological uses, and its overall significance remain uncertain. Anthropic said laboratory work to investigate the candidates is already underway, but offered no timeline for definitive experimental confirmation or application. Outside researchers reacted with cautious interest. Feng Zhang, a pioneer in CRISPR technology at MIT and the Broad Institute, reviewed Anthropic's preprint and described the finding as "genuinely intriguing," while others noted the project as an example of AI helping generate biological hypotheses. Commentators also pointed out that human scientists reviewed Claude's outputs and conducted the wet-lab experiments that will be required to validate and characterize the system. The announcement drew market attention: shares of several gene-editing companies moved after the news. Anthropic's release follows earlier high-profile claims about Claude's capabilities — including a previous result involving cryptography that required extensive human verification. For now, the confirmed elements are a computationally identified protein pattern judged noteworthy by at least one external expert and the start of experimental follow-up; whether ART has practical or scientific importance is unresolved.